Antiviral Potential of Indian Medicinal Plants Against Influenza and SARS-CoV: A Systematic Review

Abstract

The COVID-19 pandemic has posed a significant threat to human health due to the lack of drugs that can potentially act against SARS-CoV -2. Also, even after the emergency approval of WHO, the vaccines’ efficacy is still a question, and people are getting reinfections. Previous studies have demonstrated the efficacy of traditional medicinal plants against influenza and SARS coronavirus. The present article aims to review potential phytochemicals from Indian medicinal plants that may be used against SARS-CoV-2. Articles published in the English language between 1992 and 2021 were retrieved from Embase, PubMed, and Google scholar using relevant keywords, and the scientific literature on efficacies of Indian medicinal plants against SARS-CoV and influenza virus were analyzed. The initial search revealed 1304 studies, but, on subsequent screening, 115 eligible studies were reported. Twenty research articles investigating traditional medicinal plant extracts and metabolites against SARS-CoV and influenza A virus in in vitro and in vivo systems satisfied the search criteria. The studies reported that plant extracts and active compounds such as glycyrrhizin, 14-α-lipoyl andrographolide, and curcumin from medicinal plants such as Yashtimadhu ( Glycyrrhiza glabra), Bhunimba ( Andrographis paniculata), and Haridra ( Curcuma longa) are effective against the various phases of the virus life cycle, viz., virus-host cell attachment, viral replication, 3CL protease activity, neuraminidase activity, adsorption and penetration of the virus. As per ancient Indian literature, plants in Ayurveda possess Rasayana (revitalizing) and Jwara hara (antipyretic, anti-inflammatory) properties. This evidence may be used to conduct experimental and clinical trials to study the underlying mechanisms and efficacy of antiviral properties of Indian medicinal plants against SARS-CoV-2.

The Mechanism of Chaiyin Particles in the Treatment of COVID-19 Based on Network Pharmacology and Experimental Verification

“…65,66 In addition, many studies have investigated whether traditional medicinal plant extracts exhibit anti-SARS-CoV-2 activity. [67][68][69][70] Our experiments investigated the effects of CYP and monomer drugs on the proliferation ability of A549 cells at different times and found that longer treatment times and higher drug concentrations have a positive effect on the inhibition of A549 cell proliferation. With experimental durations of 24 h and 48 h, the IC50 values of CYP in A549 cells were 21.06 mg/mL and 12.73 mg/mL, respectively.…”

“…65,66 In addition, many studies have investigated whether traditional medicinal plant extracts exhibit anti-SARS-CoV-2 activity. 67-70…”

Structure-Based In Silico Approaches Reveal IRESSA as a Multitargeted Breast Cancer Regulatory, Signalling, and Receptor Protein Inhibitor

“…As the disease progresses, cancer cells have the potential to infiltrate nearby tissues and lymph nodes and, in more advanced stages, disseminate through the bloodstream to distant organs, such as the lungs, liver, bones and brain, posing considerable challenges to effective treatment and prognosis [ 3 ]. The diagnosis of breast cancer involves a multifaceted approach, encompassing various methods [ 4 , 5 , 6 , 7 , 8 ]. Mammography, which utilises X-rays, is a pivotal screening tool for detecting lumps and abnormalities.…”

Molecular docking analysis of mefluhybenamine with lung cancer targets

“…However, the side effects still need to be assessed for accurate interpretation [13][14][15][16][17][18]. During this study, we identified the compound name (2R,3R)- [19][20][21][22][23][24]. Further, the study was extended to the molecular dynamics simulation for 100ns and examined various outputs.…”